Life Sciences

Gessel and Jonak i Partnerzy Advise on Pure Biologics Public and Private Offerings

Gessel has advised Pure Biologics on its public offering of shares carried out under an accelerated book-building program and the private offering of new company shares. Jonak i Partnerzy advised the managers.

Closing: INVL Baltic Sea Growth Fund Acquisition of Nemunas and Egles Sanatorija Now Closed

On December 29, 2022, Sorainen announced that INVL Baltic Sea Growth Fund’s acquisition of Nemunas and Egles Sanatorija (reported by CEE Legal Matters on June 13, 2022) had closed.

Dorda and Schoenherr Advise on Croma-Pharma and EHC Business Combination Agreement

Dorda, working with Loyens & Loeff, has advised Croma-Pharma on entering into a business combination agreement with the European Healthcare Acquisition & Growth Company. Schoenherr, working with Sullivan & Cromwell and Houthoff, advised EHC.

D&B David si Baias Advises Memorial Healthcare on Acquisition of Monza Oncology Hospital

PwC Legal Romanian affiliate D&B David si Baias has advised Memorial Healthcare on its acquisition of the Monza Oncology Hospital within the Enayati Medical City in Bucharest.

Deal 5: MediGroup Director Mihailo Obucina on Acquisition of Konzilijum

On December 8, CEE Legal Matters reported that BDK Advokati had advised MediGroup on its acquisition of Konzilijum. CEE In-House Matters spoke with Mihailo Obucina, Director of Strategy, M&A, and Business Development at MediGroup, to learn more about the acquisition.

BCGL and Lewczuk Lyszczarek i Wspolnicy Advises on Apeiron Synthesis Investment Round

Balicki Czekanski Gryglewski Lewczuk has advised Adamed on a minority investment in Apeiron Synthesis as part of a PLN 21 million round that also included Aper Ventures and Orlen VC. Lewczuk Lyszczarek i Wspolnicy advised Apeiron Synthesis.

Schoenherr Advises Harps Global on Acquisition of Semperit Medical Division

Schoenherr has advised Singapore-based Harps Global on its acquisition of the medical business division Sempermed from the Austrian Semperit Group for an enterprise value of EUR 115 million.